HNHelmut Neumann

Helmut Neumann

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Helmut Neumann has a total of 245 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Clinical consequences of computer-aided colorectal polyp detection

    by Pieter Sinonquel, Tom Eelbode, Oliver Pech, Dominiek De Wulf, Pieter Dewint, Helmut Neumann, Giulio Antonelli, Federico Iacopini, David Tate, Arnaud Lemmers, et al.

    Background and aim Randomised trials show improved polyp detection with computer-aided detection (CADe), mostly of small lesions. However, operator and selection bias may affect CADe’s true benefit. Clinical outcomes of increased detection have not yet been fully elucidated. Methods In this multicentre trial, CADe combining convolutional and recurrent neural networks was used for polyp detection. Blinded endoscopists were monitored in real time by a second observer with CADe access. CADe detections prompted reinspection. Adenoma detection rates (ADR) and polyp detection rates were measured prestudy and poststudy. Histological assessments were done by independent histopathologists. The primary outcome compared polyp detection between endoscopists and CADe. Results In 946 patients (51.9% male, mean age 64), a total of 2141 polyps were identified, including 989 adenomas. CADe was not superior to human polyp detection (sensitivity 94.6% vs 96.0%) but outperformed them when restricted to adenomas. Unblinding led to an additional yield of 86 true positive polyp detections (1.1% ADR increase per patient; 73.8% were Conclusion Even if CADe appears to be slightly more sensitive than human endoscopists, the additional gain in ADR was minimal and follow-up intervals rarely changed. Additional inspection of non-neoplastic lesions was increased, adding to the inspection and/or polypectomy workload.


  • Clinical validation of a computer-aided detection model for colorectal polyp detection (CAD-ARTIPOD) trial using a second observer and real-time unblinding

    by P. Sinonquel, T. Eelbode, O. Pech, D. De Wulf, P. Dewint, H. Neumann, G. Antonelli, D. J. Tate, A. Lemmers, N. D. Pilonis, et al.

    Aims This trial aimed to validate a CADe system for colorectal polyp detection versus trained endoscopists in an endoscopy blinded set-up with real-time unblinding. Methods The CAD-ARTIPOD trial is a prospective multicenter trial conducted in 9 European centers. CADe specifics were published earlier [1]. Sample size analysis for superiority required 2048 polyps assuming a difference in sensitivity of 2% with endoscopic diagnosis as gold standard. All endoscopists (ADR 20-50%) were blinded for the CADe output. A second observer classified in real time the CADe output in (1) true positive (detected/not detected by the endoscopist) (2) false negative or (3) clinically relevant or irrelevant false positive detection. If a polyp was only detected by CADe, the endoscopist was unblinded for confirmation of the finding. Histological assessment of endoscopically confirmed polyps was performed by two independent histopathologists. Results A number of 2080 polyps were collected, 1549 were histologically confirmed polyps. For the primary endpoint superiority was not reached between CADe and endoscopists (sensitivity (Sn) of 0.94 vs 0.96) (non-inferiority margin of 5%, p = 0.0216). False positive rate was 1.8/min. With histology as standard, CADe outperformed the endoscopists (Sn 0.96 versus 0.95 (p=0.03)) and showed an extra detection rate of 4.8% (Fig. [1]). Conclusions This manufacturer independent CADe system used in an innovative and competitive study design demonstrated non-inferiority in comparison to endoscopists’ polyp detection. However, with histology as gold standard CADe outperformed endoscopists. Our study also shows that “watching over a shoulder” in itself leads to higher PDR and ADR Article published online: 14 April 2023 © 2023. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

  • Top Cited Papers

    Small-bowel capsule endoscopy and device-assisted enteroscopy for diagnosis and treatment of small-bowel disorders: European Society of Gastrointestinal Endoscopy (ESGE) Guideline – Update 2022

    by Marco Pennazio, Emanuele Rondonotti, Edward J. Despott, Xavier Dray, Martin Keuchel, Tom Moreels, David S. Sanders, Cristiano Spada, Cristina Carretero, Pablo Cortegoso Valdivia, et al.

    Main Recommendations: MR1 ESGE recommends small-bowel capsule endoscopy as the first-line examination, before consideration of other endoscopic and radiological diagnostic tests for suspected small-bowel bleeding, given the excellent safety profile of capsule endoscopy, its patient tolerability, and its potential to visualize the entire small-bowel mucosa.Strong recommendation, moderate quality evidence. MR2 ESGE recommends small-bowel capsule endoscopy in patients with overt suspected small-bowel bleeding as soon as possible after the bleeding episode, ideally within 48 hours, to maximize the diagnostic and subsequent therapeutic yield.Strong recommendation, high quality evidence. MR3 ESGE does not recommend routine second-look endoscopy prior to small-bowel capsule endoscopy in patients with suspected small-bowel bleeding or iron-deficiency anemia.Strong recommendation, low quality evidence. MR4 ESGE recommends conservative management in those patients with suspected small-bowel bleeding and high quality negative small-bowel capsule endoscopy.Strong recommendation, moderate quality evidence. MR5 ESGE recommends device-assisted enteroscopy to confirm and possibly treat lesions identified by small-bowel capsule endoscopy.Strong recommendation, high quality evidence. MR6 ESGE recommends the performance of small-bowel capsule endoscopy as a first-line examination in patients with iron-deficiency anemia when small bowel evaluation is indicated.Strong recommendation, high quality evidence. MR7 ESGE recommends small-bowel capsule endoscopy in patients with suspected Crohn’s disease and negative ileocolonoscopy findings as the initial diagnostic modality for investigating the small bowel, in the absence of obstructive symptoms or known bowel stenosis.Strong recommendation, high quality evidence. MR8 ESGE recommends, in patients with unremarkable or nondiagnostic findings from dedicated small-bowel cross-sectional imaging, small-bowel capsule endoscopy as a subsequent investigation if deemed likely to influence patient management.Strong recommendation, low quality evidence. MR9 ESGE recommends, in patients with established Crohn’s disease, the use of a patency capsule before small-bowel capsule endoscopy to decrease the capsule retention rate.Strong recommendation, moderate quality evidence. MR10 ESGE recommends device-assisted enteroscopy (DAE) as an alternative to surgery for foreign bodies retained in the small bowel requiring retrieval in patients without acute intestinal obstruction.Strong recommendation, moderate quality evidence. MR11 ESGE recommends DAE-endoscopic retrograde cholangiopancreatography (DAE-ERCP) as a first-line endoscopic approach to treat pancreaticobiliary diseases in patients with surgically altered anatomy (except for Billroth II patients).Strong recommendation, moderate quality evidence.


  • Performance measures for colonoscopy in inflammatory bowel disease patients: European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative

    by Evelien Dekker, Karlijn J. Nass, Marietta Iacucci, Alberto Murino, João Sabino, Marek Bugajski, Cristina Carretero, George Cortas, Edward J. Despott, James E. East, et al.

    The European Society of Gastrointestinal Endoscopy (ESGE) presents a short list of performance measures for colonoscopy in inflammatory bowel disease (IBD) patients. Current performance measures for colonoscopy mainly focus on detecting (pre)malignant lesions. However, these performance measures are not relevant for all colonoscopy indications in IBD patients. Therefore, our aim was to provide endoscopy services across Europe and other interested countries with a tool for quality monitoring and improvement in IBD colonoscopy. Eight key performance measures and one minor performance measure were recommended for measurement and evaluation in daily endoscopy practice. * Equal first authors Article published online: 29 July 2022 © 2022. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany


  • Definition of competence standards for optical diagnosis of diminutive colorectal polyps: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement

    by Britt B. S. L. Houwen, Cesare Hassan, Veerle M. H. Coupé, Marjolein J. E. Greuter, Yark Hazewinkel, Jasper L. A. Vleugels, Giulio Antonelli, Marco Bustamante-Balén, Emmanuel Coron, George A. Cortas, et al.

    Background The European Society of Gastrointestinal Endoscopy (ESGE) has developed a core curriculum for high quality optical diagnosis training for practice across Europe. The development of easy-to-measure competence standards for optical diagnosis can optimize clinical decision-making in endoscopy. This manuscript represents an official Position Statement of the ESGE aiming to define simple, safe, and easy-to-measure competence standards for endoscopists and artificial intelligence systems performing optical diagnosis of diminutive colorectal polyps (1 – 5 mm).Methods A panel of European experts in optical diagnosis participated in a modified Delphi process to reach consensus on Simple Optical Diagnosis Accuracy (SODA) competence standards for implementation of the optical diagnosis strategy for diminutive colorectal polyps. In order to assess the clinical benefits and harms of implementing optical diagnosis with different competence standards, a systematic literature search was performed. This was complemented with the results from a recently performed simulation study that provides guidance for setting alternative competence standards for optical diagnosis. Proposed competence standards were based on literature search and simulation study results. Competence standards were accepted if at least 80 % agreement was reached after a maximum of three voting rounds.Recommendation 1 In order to implement the leave-in-situ strategy for diminutive colorectal lesions (1–5 mm), it is clinically acceptable if, during real-time colonoscopy, at least 90 % sensitivity and 80 % specificity is achieved for high confidence endoscopic characterization of colorectal neoplasia of 1–5 mm in the rectosigmoid. Histopathology is used as the gold standard.Level of agreement 95 %.Recommendation 2 In order to implement the resect-and-discard strategy for diminutive colorectal lesions (1–5 mm), it is clinically acceptable if, during real-time colonoscopy, at least 80 % sensitivity and 80 % specificity is achieved for high confidence endoscopic characterization of colorectal neoplasia of 1–5 mm. Histopathology is used as the gold standard.Level of agreement 100 %.Conclusion The developed SODA competence standards define diagnostic performance thresholds in relation to clinical consequences, for training and for use when auditing the optical diagnosis of diminutive colorectal polyps.


  • Open Access

    Editorial: understanding IBS pathophysiology through “converging channels” of research—authors’ reply

    by Madhusudan Grover, Antonio Berumen, Stephanie Peters, Ting Wei, Margaret Breen‐Lyles, William S. Harmsen, Irene Busciglio, Duane Burton, Maria Vazquez Roque, Kenneth R. DeVault, et al.

  • Open Access

    Evaluation of novel LCI CAD EYE system for real time detection of colon polyps

    by Helmut Neumann, Andreas Kreft, Visvakanth Sivanathan, Fareed Rahman, Peter R. Galle

    Background: Linked color imaging (LCI) has been shown to be effective in multiple randomized controlled trials for enhanced colorectal polyp detection. Recently, artificial intelligence (AI) with deep learning through convolutional neural networks has dramatically improved and is increasingly recognized as a promising new technique for enhancing colorectal polyp detection. Aim: This study aims to evaluate a newly developed computer-aided detection (CAD) system in combination with LCI for colorectal polyp detection. Methods: First, a convolutional neural network was trained for colorectal polyp detection in combination with the LCI technique using a dataset of anonymized endoscopy videos. For validation, 240 polyps within fully recorded endoscopy videos in LCI mode, covering the entire spectrum of adenomatous histology, were used. Sensitivity (true-positive rate per lesion) and false-positive frames in a full procedure were assessed. Results: The new CAD system used in LCI mode could process at least 60 frames per second, allowing for real-time video analysis. Sensitivity (true-positive rate per lesion) was 100%, with no lesion being missed. The calculated false-positive frame rate was 0.001%. Among the 240 polyps, 34 were sessile serrated lesions. The detection rate for sessile serrated lesions with the CAD system used in LCI mode was 100%. Conclusions: The new CAD system used in LCI mode achieved a 100% sensitivity per lesion and a negligible false-positive frame rate. Note that the new CAD system used in LCI mode also specifically allowed for detection of serrated lesions in all cases. Accordingly, the AI algorithm introduced here for the first time has the potential to dramatically improve the quality of colonoscopy.


  • Zenker's peroral endoscopic myotomy (Z-POEM) for recurrent Zenker diverticulum: not so fast!

    by Sauid Ishaq, Keith Siau, Toshio Kuwai, Chris J. Mulder, Helmut Neumann

    We congratulate Sanaei et al. for publishing their data on Z-POEM in 32 patients with recurrent Zenker diverticulum (ZD) [1]. We wish to discuss several observations. First, Z-POEM involves cricopharyngeal myotomy with distal extension by 1 – 2 cm on the esophageal side to ensure complete dissection. This runs the risk of cutting the circular muscles of the esophagus, which has no longitudinal muscle layer or serosal lining, and therefore risks perforation. Indeed, serious adverse events occurred in 4/32 patients (12.5 %), including two leaks and two mucosotomies (perforations). These are potentially life-threatening complications, which seem disproportionate to the elective nature of these cases, performed mainly on patients with mild-to-moderate symptoms (dysphagia score, interquartile range 1 – 2). Second, technical success was reported in 29 /30 patients. Given that two patients were excluded owing to technical failures, the success rate should be 29 /32 (90.6 %). Given that the median follow-up duration was 166 days, longer term outcome data remain warranted. This is because, unlike conventional septotomy, the mucosal bridge of the pouch is not dissected in Z-POEM, leaving behind a remnant pouch that can give rise to regurgitation symptoms in the long run. Third, we recently found the Dysphagia, Regurgitation, Complication (DRC) score to be superior to the Dysphagia (Dakkak) score alone in ZD. Of note, regurgitation can be a particularly disabling symptom, even in the absence of dysphagia [2]. Finally, flexible endoscopic septal division (FESD) has been shown to effectively improve symptoms in recurrent ZD, with an excellent safety profile [2] [3] [4]. The recent ESGE guidelines still regard Z-POEM as experimental and recommend its use in a research setting for the time being [5]. We invite the authors’ views on the observations discussed above. Despite the promising data, we eagerly await the longer term safety and efficacy data before considering Z-POEM as the mainstream approach, even in recurrent ZD. Publication Date: 24 June 2021 (online) © 2021. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany